AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.890
+0.160 (5.86%)
At close: Nov 4, 2024, 4:00 PM
2.642
-0.248 (-8.59%)
After-hours: Nov 4, 2024, 7:39 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $851.58 million as of November 5, 2024. Its market cap has decreased by -31.40% in one year.
Market Cap
851.58M
Enterprise Value
274.72M
1-Year Change
-31.40%
Ranking
Category
Stock Price
$2.89
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $5.33B to $851.58M, a decrease of -84.01%. That is a compound annual growth rate of -37.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 804.40M | -51.45% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.37% |
| Dec 31, 2020 | 10.70B | 100.92% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 881.01M |
| Aveanna Healthcare Holdings | 871.45M |
| Tyra Biosciences | 867.08M |
| Rapport Therapeutics | 863.94M |
| Neurogene | 857.58M |
| Capricor Therapeutics | 845.38M |
| Cronos Group | 845.02M |
| Embecta | 838.98M |